Effects of Anticholinergic or Long-Acting Beta 2 Agonist on FeNO and Pulmonary Function in SCI



Status:Active, not recruiting
Conditions:Hospital, Orthopedic
Therapuetic Areas:Orthopedics / Podiatry, Other
Healthy:No
Age Range:18 - 65
Updated:4/21/2016
Start Date:August 2011
End Date:August 2016

Use our guide to learn which trials are right for you!

Acute and Chronic Effects of an Anticholinergic Agent or a Long-Acting Beta 2 Agonist on Levels of Exhaled Nitric Oxide and Pulmonary Function in Persons With Tetraplegia

To determine the acute and chronic effects of a short course of treatment on spinal cord
injured (SCI) individuals with either an anticholinergic agent (tiotropium) or with a β₂
agonist (Salmeterol) on:

- Fraction of expired NO (FeNO)

- Selected Biomarkers of inflammation in exhaled breath condensates (EBC)

- Pulmonary function, as measured by pulmonary function tests and body plethysmography


Inclusion Criteria:

1. Chronic Spinal Cord Injury (>1 year post-injury)

2. All American Spinal Injury Association (ASIA) classifications

3. Stable tetraplegia (level of injury C3-C8, non-ventilator dependent)

4. Age 18-65 years

Exclusion Criteria:

1. Smoking, active or history of smoking within last 6 months;

2. Active respiratory disease;

3. Known history of asthma during lifetime or recent (within 3 months) respiratory
infections;

4. Use of medications known to affect the respiratory system;

5. Use of medications known to alter airway caliber;

6. Coronary heart and/or artery disease;

7. Hypertension;

8. Adrenal insufficiency;

9. Pregnancy;

10. Severe Milk Protein Allergy;

11. Lack of mental capacity to give informed consent;

12. Previous allergic reaction or hypersensitivity to salmeterol or tiotropium;

13. Individuals taking medication(s) with known /potential drug interactions or suggested
therapy modification for concomitant use with salmeterol or tiotropium such as:

(1) selective alpha-/beta- blockers: carvedilol, labetalol; (2) non-selective
beta-blockers: Carteolol; Levobunolol; Metipranolol; Nadolol; Penbutolol; Pindolol;
Propranolol; Sotalol; Timolol); (3) CYP3A4 Inhibitors: (e.g, Atazanavir; Clarithromycin;
Conivaptan; Darunavir; Delavirdine; Fosamprenavir; Imatinib; Indinavir; Isoniazid;
Itraconazole; Ketoconazole; Lopinavir; Nefazodone; Nelfinavir; NiCARdipine; Posaconazole;
QuiNIDine; Ritonavir; Saquinavir; Telithromycin; Voriconazole; (4) Iobenguane I 123 /
Sympathomimetics: Albuterol; Aminophylline; Arformoterol; Armodafinil; Benzphetamine;
Caffeine; Dexmethylphenidate; Dextroamphetamine; Diethylpropion; Dipivefrin; DOBUTamine;
DOPamine; Doxapram; Dyphylline; EPHEDrine; EPINEPHrine; Fenoterol; Formoterol;
Isometheptene; Levalbuterol; Levonordefrin; Lisdexamfetamine; Metaproterenol;
Methamphetamine; Methylphenidate; Midodrine; Modafinil; Naphazoline; Norepinephrine;
Oxymetazoline; Phendimetrazine; Phentermine; Phenylephrine; Pirbuterol; Propylhexedrine;
Pseudoephedrine; Sibutramine; Terbutaline; Theophylline; Xylometazoline.
We found this trial at
2
sites
West Orange, New Jersey 07052
2387
mi
from 98109
West Orange, NJ
Click here to add this to my saved trials
Bronx, New York 10468
2401
mi
from 98109
Bronx, NY
Click here to add this to my saved trials